RIFAXIMIN AND ELUXADOLINE UTILIZATION FOR IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) IN THE UNITED STATES AND BUDGET IMPACT ANALYSIS OF SWITCHING FROM ELUXADOLINE TO RIFAXIMIN

被引：0
|
作者：
Bloudek, L. M. [1 ]
Bozkaya, D. [1 ]
O'Hara, K. [2 ]
Kirby, S. K. [2 ]
Shah, S. [2 ]
机构：
[1] Xcenda LLC, Palm Harbor, FL USA
[2] Valeant Pharmaceut, Bridgewater, NJ USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.04.561
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PGI9
引用
收藏
页码：S83 / S83
页数：1
相关论文
共 50 条
  • [1] Impact of Colonoscopy Timing on Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D)
    Lacy, Brian E.
    Lembo, Anthony
    Pimental, Mark
    Heimanson, Zeev
    Cash, Brooks D.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S295 - S295
  • [2] Update on the Management of Diarrhea-Predominant Irritable Bowel Syndrome: Focus on Rifaximin and Eluxadoline
    Rivkin, Anastasia
    Rybalov, Sergey
    PHARMACOTHERAPY, 2016, 36 (03): : 300 - 316
  • [3] Responders Analysis in Patients With Diarrhea-Predominant Irritable Bowel Syndrome IBS-D) Treated With Rifaximin
    Lembo, Anthony J.
    Heimanson, Zeev
    Pimentel, Mark
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S236 - S236
  • [4] Lactulose Breath Testing Predicts Response to Rifaximin for Cardinal Irritable Bowel Syndrome With Diarrhea (IBS-D)
    Rezaie, Ali
    Heimanson, Zeev
    Israel, Robert J.
    McCallum, Richard
    Pimentel, Mark
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S269 - S269
  • [5] EFFICACY OF RIFAXIMIN IN PATIENTS WITH DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-D) AND PRIOR USE OF IBS MEDICATIONS
    Lembo, Anthony J.
    Rao, Satish S.
    Rezaie, Ali
    Heimanson, Zeev
    Pimentel, Mark
    GASTROENTEROLOGY, 2018, 154 (06) : S499 - S499
  • [6] RIFAXIMIN IS EFFICACIOUS FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) IN ADULTS PREVIOUSLY TREATED WITH OTHER IBS MEDICATIONS
    Rao, Satish S.
    Schoenfeld, Philip S.
    Heimanson, Zeev
    Rezaie, Ali
    Lacy, Brian E.
    GASTROENTEROLOGY, 2020, 158 (06) : S852 - S852
  • [7] Eluxadoline Demonstrates Efficacy for the Treatment of Irritable Bowel Syndrome (IBS) With Diarrhea (IBS-D) Among Multiple Clinically Relevant Patient Subgroups
    Lacy, Brian E.
    Chey, William
    Lembo, Anthony J.
    Dove, Leonard S.
    Covington, Paul S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S747 - S747
  • [8] Treatment-free interval (TFI): A novel approach to assessing real-world treatment response among patients with irritable Bowel syndrome with diarrhea (IBS-D) treated with rifaximin or eluxadoline
    Lacy, B. E.
    Gagnon-Sanschagrin, P.
    Heimanson, Z.
    Bungay, R.
    Bellefleur, R.
    Guerin, A.
    Dashputre, A.
    Bumpass, B.
    Borroto, D.
    Joseph, G.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2023, 35
  • [9] RIFAXIMIN REPEAT TREATMENT FOR DIARRHEA PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-D) AND IMPACT ON CLOSTRIDIUM DIFFICILE INFECTION DEVELOPMENT Mark
    Pimentel, Mark
    Schoenfeld, Philip S.
    Heimanson, Zeev
    Cash, Brooks D.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 : S332 - S332
  • [10] RIFAXIMIN REPEAT TREATMENT FOR DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-D) AND IMPACT ON CLOSTRIDIUM DIFFICILE INFECTION DEVELOPMENT
    Pimentel, Mark
    Schoenfeld, Phillip
    Heimanson, Zeev
    Cash, Brooks D.
    GASTROENTEROLOGY, 2018, 154 (06) : S499 - S500
12345